Number coding for identification of subtypes of coded types of solid phase carriers

• US 8,615,367 B2
• Filed: 03/24/2011
• Issued: 12/24/2013
• Est. Priority Date: 09/18/2003
• Status: Expired due to Fees

• Current Assignee: BioArray Solutions Limited (Werfen SA)
• Original Assignee: BioArray Solutions Limited (Werfen SA)
• Inventors: Seul, Michael, Chau, Chiu Wo, Tan, Enqing
• Primary Examiner(s): Riggs, II, Larry D
• Application Number:
  US13/071,055
• Publication Number:
  US 20110184655A1
• Time in Patent Office: 1,006 Days
• Field of Search: None
• US Class Current: 702/19
• CPC Class Codes: G01N 33/543 with an insoluble carrier for immobilising immunochemicals
• CPC Class Codes: G01N 33/54313 the carrier being characterised by its particulate form
• CPC Class Codes: G01N 33/564 for pre-existing immune complex or autoimmune disease , i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
• CPC Class Codes: G01N 33/6845 Methods of identifying protein-protein interactions in protein mixtures

Abstract

Disclosed is number coding of pairs (“doublets”) or small sets (“multiplets”) of solid phase carriers which provides distinguishable subtypes of a given type of such carriers, where each carrier type is distinguishable on the bases of a different code. Such number coding is useful for augmenting a coding system, such as a color code, and thereby effectively multiplying the number of “colors” (distinguishable sub-types). It can be applied, for example, to determine whether a sample is homozygous or heterozygous at a number of different sites for one of two different alleles, where the same color code is applied for each of the two alleles, and the alleles with the same color code are distinguished by knowing how many carriers are associated with molecules which detect each different allele.

Claims

1. A method of employing numerical encoding of particles in a bioassay, comprising:

providing uniquely color encoded groups of particles having ligands attached to said particles wherein each group of particles comprises two or more subtypes of particles having different ligands attached to said two or more subtypes of particles;

wherein the number of each subtype of particles provided has a unique decomposition into one or more summands, such that no partial sum of one or more summands can be obtained in any other way of combining summands, and no summand is itself the sum of two or more of the other summands;

conducting an assay by contacting the groups of particles with a sample comprising analytes;

determining, for each group of particles, the number of particles generating a positive assay signal, indicating reaction between a ligand and an analyte;

comparing, for each group of particles, said number of particles generating a positive assay signal with the number of particles of each subtype; and

determining, for each group of particles, the analytes present in the sample based on said comparing step.

2. The method of claim 1, wherein the different ligands attached to said two or more subtypes of particles comprise one of four oligonucleotide probes, each probe differing by having one of the nucleotides A, C, G or T in the 3′

terminal position.

3. The method of claim 2 wherein a positive assay signal is generated by an elongation reaction.

4. A method of employing numerical coding of particles, comprising:

providing uniquely color encoded groups of particles having peptides or antibodies attached to said particles, wherein each group of particles comprises two or more subtypes of particles having different peptides or antibodies attached to said two or more subtypes of particles;

wherein the number of each subtype of particles provided has a

unique decomposition into one or more summands, such that no partial sum of one or more summands can be obtained in any other way of combining summands, and no summand is itself the sum of two or more of the other summands;

conducting an assay by contacting the groups of particles with a sample comprising analytes;

determining for each group of particles, the number of particles generating a positive assay signal, indicating reaction between a peptide or antibody and an analyte;

comparing for each group of particles, said number of particles generating a positive assay signal with the number of particles of each subtype; and

determining for each group of particles, the analytes present in the sample based on said comparing step.

5. The method of claim 4 wherein the ligands comprise peptides and the analytes comprise specific epitopes of auto-antibodies in the sample.

6. The method of claim 5, further comprising adding a secondary detection antibody which binds to auto-antibodies bound to the peptides.

7. The method of claim 4 wherein the color encoded groups comprise different colors corresponding to different groups of peptide ligands, each such group of peptides corresponding to epitopes of a specific autoantibody.

8. The method of claim 4 wherein two or more different types of peptides are attached to beads of the same group.